Lutris Pharma Is A Clinical Stage Biopharmaceutical Company Focused On Improving Anti Cancer Therapy Effectiveness And Quality Of Life For Patients Who Are Being Treated With Egfrepidermal Growth Factor Receptorinhibitors Or With Radiationwhere Dermal Toxicity Often Leads To A Reduction Of Anti Cancer Therapy Compliancethe Company Aims To Provide Novel Topical Therapies In Order To Mitigate These Side Effectslutris Pharma S Lead Assetlut014A Topical B Raf Inhibitoris A Proprietaryfirst In Classsmall Molecule Currently In A Phase 2 Clinical Trial In Metastatic Colorectal Cancer Patients With Egfr Inhibitor Induced Acneiform Lesions And A Phase 1 2 Study For The Treatment Of Radiation Induced Dermatitis
No conferences found for this company.
| Company Name | Lutris Pharma Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
